On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitor.
O'Shea
Esther
E
Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain.
Sanchez
Veronica
V
Camarero
Jorge
J
Green
A Richard
AR
Colado
M Isabel
MI
D000818:Animals; D001549:Benzamides / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D015259:Dopamine Agents / Q000009:adverse effects*; D008297:Male; D008694:Methamphetamine / Q000009:adverse effects*; D051379:Mice; D008810:Mice, Inbred C57BL; D018696:Neuroprotective Agents / Q000494:pharmacology*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D012007:Rectum
D001549:Benzamides; D015259:Dopamine Agents; D018696:Neuroprotective Agents; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D008694:Methamphetamine; C037689:benzamide